Rachel Zoe Baumann, LPC,MA,SYC,NCSP | |
597 Westport Ave, Norwalk, CT 06851-4440 | |
(203) 533-1252 | |
Not Available |
Full Name | Rachel Zoe Baumann |
---|---|
Gender | Female |
Speciality | Counselor - Professional |
Location | 597 Westport Ave, Norwalk, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053908038 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TS0200X | Psychologist - School | C082020000582 (Connecticut) | Secondary |
101YP2500X | Counselor - Professional | 46.005359 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rachel Zoe Baumann, LPC,MA,SYC,NCSP 82 Front St Apt A, Groton, CT 06340-5786 Ph: (203) 533-1252 | Rachel Zoe Baumann, LPC,MA,SYC,NCSP 597 Westport Ave, Norwalk, CT 06851-4440 Ph: (203) 533-1252 |
News Archive
Although exercise is known to enhance cognitive function and improve mental health, the neurological mechanisms of this link are unknown. Now, researchers from Japan have found evidence of the missing link between aerobic fitness and cognitive function.
A new study has found that an osteoporosis drug protects against the bone damaging side effects of certain breast cancer medications. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that some breast cancer patients could take zoledronic acid in addition to their anti-cancer medications to maintain bone health.
Smile Brands Inc., the nation's leading provider of business support services to dental groups in the United States, today announced the grand opening of a new Monarch Dental office in Granbury, TX which will be the 55th in the Dallas-Fort Worth area.
Pharmion Corporation, along with its collaborator MethylGene Inc., today announced that the U.S. Food and Drug Administration (FDA) has designated the Companies' histone deacetylase (HDAC) inhibitor, MGCD0103, as an Orphan Drug for the treatment of Hodgkin's lymphoma in the United States.
› Verified 5 days ago